-
1Academic Journal
Authors: Nychytailo, M. Yu., Bulyk, I. I.
Source: Surgery of Ukraine; No. 2 (2018); 70—73 ; Хирургия Украины; № 2 (2018); 70—73 ; Хірургія України; № 2 (2018); 70—73 ; 2521-697X ; 1818-5398
Subject Terms: антибіотикотерапія, антибіотикопрофілактика, гострий калькульозний холецистит, гострий панкреатит, холедохолітіаз, непрохідність жовчних проток, ципрофлоксацин, антибиотикотерапия, антибиотикопрофилактика, острый калькулезный холецистит, острый панкреатит, холедохолитиаз, непроходимость желчных протоков, antibiotic therapy, antibiotic prophylaxis, acute calculous cholecystitis, acute pancreatitis, choledocholithiasis, bile duct obstruction, ciprofloxacin
File Description: application/pdf
Relation: https://surgukraine.co.ua/article/view/SU2018270/131215; https://surgukraine.co.ua/article/view/SU2018270
Availability: https://surgukraine.co.ua/article/view/SU2018270
-
2Academic Journal
Authors: M. V. Berkut, A. M. Belyaev, N. F. Krotov, O. V. Zaozerskii, A. K. Nosov, М. В. Беркут, А. М. Беляев, Н. Ф. Кротов, О. В. Заозерский, А. К. Носов
Source: Siberian journal of oncology; Том 23, № 5 (2024); 112-125 ; Сибирский онкологический журнал; Том 23, № 5 (2024); 112-125 ; 2312-3168 ; 1814-4861
Subject Terms: ERAS, antibiotic prophylaxis, complications, surgical site infection, upper urinary tract infections, антибиотикопрофилактика, осложнения, раневая инфекция, инфекции верхних мочевыводящих путей
File Description: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/3275/1276; Antonelli L., Sebro K., Lahmar A., Black P.C., Ghodoussipour S., Hamilton-Reeves J.M., Shah J., Bente Thoft J., Lerner S.P., Llorente C., Lucca I., Preston M.A., Psutka S.P., Sfakianos J.P., Vahr Lauridsen S., Williams S.B., Catto J., Djaladat H., Kassouf W., Loftus K., Daneshmand S., Fankhauser C.D.; Enhanced Recovery After Surgery ERAS Cystectomy Committee. Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review. Eur Urol Focus. 2023; 9(4): 631–6. doi:10.1016/j.euf.2023.01.012.; Maibom S.L., Joensen U.N., Poulsen A.M., Kehlet H., Brasso K., Røder M.A. Short-term morbidity and mortality following radical cystectomy: a systematic review. BMJ Open. 2021; 11(4). doi:10.1136/bmjopen2020-043266.; Lawrentschuk N., Colombo R., Hakenberg O.W., Lerner S.P., Månsson W., Sagalowsky A., Wirth M.P. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol. 2010; 57(6): 983–1001. doi:10.1016/j.eururo.2010.02.024.; Асланов Б.И., Зуева Л.П., Колосовская Е.Н., Любимова А.В., Хорошилов В.Ю., Долгий А.А., Дарьина М.Г., Техова И.Г. Принципы организации периоперационной антибиотикопрофилактики в учреждениях здравоохранения. Федеральные клинические рекомендации. М., 2014. 42 c.; Ross J.P.J., Breau R.H., Vigil H., Hickling D.R., Angel J.B., Mallick R., Cagiannos I., Morash C., Lavallée L.T. Association between radical cystectomy prophylactic antimicrobial regimen and postoperative infection. Can Urol Assoc J. 2021; 15(12): 644–51. doi:10.5489/cuaj.7158.; Moher D., Liberati A., Tetzlaff J., Altman D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7). doi:10.1371/journal.pmed.1000097.; Viechtbauer W. Conducting metaanalyses in R with the metafor package. Journal of Statistical Software. 2010; 36 (3): 1–48. doi:10.18637/jss.v036.i03.; Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Schünemann H.J.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650): 924–6. doi:10.1136/bmj.39489.470347.AD.; Krasnow R.E., Mossanen M., Koo S., Kubiak D.W., Preston M.A., Chung B.I., Kibel A.S., Chang S.L. Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States. J Urol. 2017; 198(2): 297–304. doi:10.1016/j.juro.2017.02.3340.; Numao N., Fujiwara R., Uehara S., Yasuoka S., Fujiwara M., Komai Y., Yuasa T., Yamamoto S., Fukui I., Yonese J. Intraoperative Only versus Extended Duration Use of Antimicrobial Prophylaxis for Infectious Complications in Radical Cystectomy with Intestinal Urinary Diversion. Urol Int. 2020; 104(11–12): 954–59. doi:10.1159/000509881.; Kim C.J., Kim K.H., Song W., Lee D.H., Choi H.J. Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder. Medicine (Baltimore). 2018; 97(47). doi:10.1097/MD.0000000000013196.; Werntz R.P., Martinez-Acevedo A., Amadi H., Kopp R., La Rochelle J., Koppie T., Amling C., Sajadi K.P. Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source. Urol Oncol. 2018; 36(5). doi:10.1016/j.urolonc.2017.12.025.; Pariser J.J., Anderson B.B., Pearce S.M., Han Z., Rodriguez J.A. 3rd, Landon E., Pisano J.C., Smith N.D., Steinberg G.D. The efect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy. Urol Oncol. 2016; 34(3). doi:10.1016/j.urolonc.2015.10.007.; Altobelli E., Buscarini M., Gill H.S., Skinner E.C. Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol. Bladder Cancer. 2017; 3(1): 51–56. doi:10.3233/BLC-160061.; Jasovský D., Littmann J., Zorzet A., Cars O. Antimicrobial resistance-a threat to the world’s sustainable development. Ups J Med Sci. 2016; 121(3): 159–64. doi:10.1080/03009734.2016.1195900.; Iskandar K., Sartelli M., Tabbal M., Ansaloni L., Baiocchi G.L., Catena F., Coccolini F., Haque M., Labricciosa F.M., Moghabghab A., Pagani L., Hanna P.A., Roques C., Salameh P., Molinier L. Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria. World J Emerg Surg. 2019. doi:10.1186/s13017-019-0266-x.; Котов С.В., Хачатрян А.Л., Котова Д.П., Безруков Е.А., Простомолотов А.О., Носов А.К., Рева С.А., Семенов Д.В., Павлов В.Н., Измайлов А.А., Денейко А.С. Анализ результатов применения протокола ERAS в реальной клинической практике при радикальной цистэктомии (первое проспективное мультицентровое исследование в России). Урология. 2019; (6): 60–66. doi:10.18565/urology.2019.6.60-66.; Peerbocus M., Wang Z.J. Enhanced Recovery After Surgery and Radical Cystectomy: A Systematic Review and Meta-Analysis. Res Rep Urol. 2021; 13: 535–47. doi:10.2147/RRU.S307385.; Wang Y.L., Zhang F.B., Zheng L.E., Yang W.W., Ke L.L. Enhanced recovery after surgery care to reduce surgical site wound infection and postoperative complications for patients undergoing liver surgery. Int Wound J. 2023; 20(9): 3540–49. doi:10.1111/iwj.14227.; Беркут М.В., Мамижев Э.М., Галунова Т.Ю., Новик А.В., Румянцева Д.И., Носов А.К. Клиническое исследование: мультицентровое исследование по использованию превентивной антибиотикотерапии при цистэктомии в условиях раннего послеоперационного восстановления (исследование MACS). Вопросы онкологии. 2023; 69(3): 415–21. doi:10.37469/0507-3758-2023-69-3-415-421.; https://www.siboncoj.ru/jour/article/view/3275
-
3Academic Journal
Authors: М. В. Беркут, А. М. Беляев, Т. Ю. Галунова, Н. И. Тяпкин, С. А. Рева, А. К. Носов
Contributors: Исследование проведено при поддержки гранта РакФонда от 22.05.2022 г.
Source: Malignant tumours; Том 14, № 3s1 (2024); 63-71 ; Злокачественные опухоли; Том 14, № 3s1 (2024); 63-71 ; 2587-6813 ; 2224-5057
Subject Terms: ERAS протокол, радикальная цистэктомия, антибиотикопрофилактика, инфекционные осложнения
File Description: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/1349/956; Witjes J.A., Bruins H.M., Cathomas R. et.al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79(1):82–104. https://doi.org/10.1016/j.eururo.2020.03.055; Hautmann R.E., de Petriconi R.C., Volkmer B.G. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010;184(3):990–1235. https://doi.org/10.1016/j.juro.2010.05.037; Даренков С.П., Кривобородов Г.Г., Котов С.В. Осложнения радикальной цистэктомии с орто- и гетеротопической кишечной пластикой (обзор литературы). Вестник РГМУ 2013;4:49–53.; Lawrentschuk N., Colombo R., Hakenberg O.W., et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 2010;57(6):983–1001. https://doi.org/10.1016/j.eururo.2010.02.024; Носов А.К., Рева С.А., Джалилов И.Б., Петров С.Б. Радикальная цистэктомия при раке мочевого пузыря: сравнение ранних хирургических осложнений при лапароскопической, открытой и видеоассистированyой операции. Онкоурология 2015;11(3):71–78. https://doi.org/10.17650/1726-9776-2015-11-3-71-78; Котов С.В., Хачатрян А.Л., Котова Д.П. и соавт. Анализ результатов применения протокола ERAS в реальной клинической практике при радикальной цистэктомии (первое проспективное мультицентровое исследование в России). Урология 2019;6:60–66. https://dx.doi.org/10.18565/urology.2019.6.60-66; Peerbocus M., Wang Z.J. Enhanced Recovery After Surgery and Radical Cystectomy: A Systematic Review and Meta-Analysis. Res Rep Urol 2021;13:535–547. https://dx.doi.org/10.2147/RRU.S307385; Профилактика инфекций области хирургического вмешательства. Клинические рекомендации под редакцией Брико Н.И., Божкова С.А., Брусина Е.Б. и соавт. Н. Новгород: Изд-во «Ремедиум Приволжье» 2018:72; Асланов Б.И., Зуева Л.П., Колосовская Е.Н. и соавт. Принципы организации периоперационной антибиотикопрофилактики в учреждениях здравоохранения. Федеральные клинические рекомендации. М; 2014:42; Altemeier W.A., Burke J.F., Pruitt B.A.Jr., Sanduskiy W.R. Manual on control of infection in surgical patients. Philadelphia: Lippincott 1972:20–32; Атдуев В.А., Гасраталиев В.Э., Ледяев Д.С., Шевелев И.С., Бельский В.А. Предикторы послеоперационных осложнений радикальной цистэктоми. Онкология, Журнал им. П.А. Герцена 2019;8(5):348–357. https://dx.doi.org/10-17116/onkolog20198051348; Беркут М. В, Мамижев Э.М., Галунова Т.Ю. и соавт. Клиническое исследование: мультицентровое исследование по использованию превентивной антибиотикотерапии при цистэктомии в условиях раннего послеоперационного восстановления (исследование MACS). Вопросы онкологии 2023;69(3):415–421. https://doi.org/10.37469/0507-3758-2023-69-3-415-421; Berkut M.V., Belyaev A.M., Galunova T.Yu., et al. Effectiveness of Prolonged Antibiotic Prophylaxis in Radical Cystectomy: Preliminary Analysis of the MACS Randomized Clinical Trial. Bladder Cancer 2024;1–12. https://doi.org/10.3233/BLC-240012; Berkut M.V., Belyaev A.M., Galunova T.Y. et.al. Prolonged 120-h meropenem antibiotic prophylaxis in radical cystectomy compared to 24h standard antibiotic prophylaxis: Final analysis of the randomized clinical trial. Arab J Urol 2024;22(4):235–242. https://doi.org/10.1080/20905998.2024.2373399; Volland H., Girlich D., Laguide M., et al. Improvement of the Immunochromatographic NG-Test Carba 5 Assay for the Detection of IMP Variants Previously Undetected. Antimicrob Agents Chemother 2019;64(1):e01940–19. https://doi.org/10.1128/AAC.01940-19; Van Hemelrijck M., Thorstenson A., Smith P. et.al. Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients. BJU Int 2013;112(8):1113–1120. https://doi.org/110.1111/bju.12239; Clifford T.G., Katebian B., Van Horn C.M., et al. Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients. World J Urol 2018;36(5):775–781. https://doi.org/10.1007/s00345-018-2181-2; Pellegrino F., Leni R., Basile G., et al. Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center. World J Urol 2024;42(1):270. https://doi.org/10.1007/s00345-024-04970-x; Williams S.B., Cumberbatch M.G.K., Kamat A.M., et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur Urol 2020;78(5):719–730. https://doi.org/10.1016/j.eururo.2020.06.039; Черненькая Т.В., Борисова Л.А., Воробьева Т.Ю. и соавт. Карбапенемазы, продуцируемые полирезистентными штаммами Klebsiella pneumoniae, выделенными от пациентов реанимационного профиля. Журнал им. Н.В. Склифосовского Неотложная медицинская помощь 2024;13(1):22–28. https://doi.org/10.23934/2223-9022-2024-13-1-22-28; Radko M, Guzek A, Syryło T, Rybicki Z, Zieliński H. Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing Enterobacterales bacteriuria scheduled for urological procedures. Cent European J Urol 2022;75(2):209–215. https://doi.org/10.5173/ceju.2022.0109; Невежина А.В. Карбапенемазы как фактор устойчивости к антибактериальным препаратам. Acta biomedica scientifica 2020;5(6):95–105. https://doi.org/10.29413/ABS.2020-5.6.11; Полищук А.Г., Якубович Е.И., Полухина О.В. и соавт. Карбапенемаза-продуцирующие грамотрицательные бактерии в специализированном стационаре Санкт-Петербурга. Инфекция и иммунитет 2017;7(2):181–192. https://doi.org/10.15789/2220-7619-2017-2-181-192; Эйдельштейн М.В., Шайдуллина Э.Р., Иванчик Н.В. и соавт. Антибиотикорезистентность клинических изолятов Klebsiella pneumoniae и Escherichia coli в стационарах России: результаты многоцентрового эпидемиологического исследования. Клиническая микробиология и антимикробная химиотерапия 2024;26(1):67–78. https://doi.org/10.36488/cmac.2024.1.67-78; Platt, J.J., Ramanathan, M.L., Crosbie, R.A., et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol 2012;19(13):4168–4177. https://doi.org/10.1245/s10434-012-2498-9; Charbonneau J., Brind ’Amour A., Sideris L., et al. Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study. Ann Surg Oncol 2024. https://doi.org/10.1245/s10434-024-15986-3; Straatman J., Harmsen A.M.K., Cuesta M.A. et.al. Predictive Value of C-Reactive Protein for Major Complications after Major Abdominal Surgery: A Systematic Review and Pooled-Analysis. PLoS One 2015;10(7):e0132995. https://doi.org/10.1371/journal.pone.0132995; https://www.malignanttumors.org/jour/article/view/1349
-
4Academic Journal
-
5Academic Journal
Authors: Yuliana Babina, Oleksandr Nazarchuk, Dmytro Dmytriiev
Source: Perioperative Medicine, Vol 4, Iss 1 (2021)
Perioperaciina Medicina; Vol. 4 No. 1 (2021): Perioperative Medicine; 11-17
Perioperaciina Medicina; Том 4 № 1 (2021): Perioperative Medicine; 11-17Subject Terms: sulbactam, antibiotic prophylaxis, cefoperazone, сульбактам, цефалоспорини, 3. Good health, антибиотикопрофилактика, Лаксерс, 03 medical and health sciences, 0302 clinical medicine, цефоперазон, cephalosporins, цефалоспорины, антибіотикопрофілактика, Medicine, Laxers
File Description: application/pdf
-
6Academic Journal
Authors: Mekhaeel M.S., Khelifi Ibrahim, Amine A.A., Rizk M.G.
Source: Spravočnik vrača obŝej praktiki (Journal of Family Medicine). :46-50
Subject Terms: 0301 basic medicine, antibiotic prophylaxis, медицинская хирургия, 3. Good health, антибиотикопрофилактика, 03 medical and health sciences, 0302 clinical medicine, Medical surgery, antibiotic, resistance to antibiotics, антибиотик, резистентность к антибиотикам
-
7
-
8Academic Journal
Authors: A. E. Gulyaeva, E. A. Kim, Z. V. Grigorievskaya, D. A. Denchik, K. V. Gagulaeva, D. V. Khaylenko, A. A. Rumyantsev, A. V. Petrovsky, А. Э. Гуляева, Е. А. Ким, З. В. Григорьевская, Д. А. Денчик, К. В. Гагулаева, Д. В. Хайленко, А. А. Румянцев, А. В. Петровский
Source: Surgery and Oncology; Том 13, № 2 (2023); 38-45 ; Хирургия и онкология; Том 13, № 2 (2023); 38-45 ; 2949-5857
Subject Terms: антибиотикопрофилактика, reconstructive surgery, allomaterials, surgical site infections, antibiotic prophylaxis, реконструктивные операции, алломатериалы, инфекции области хирургического вмешательства
File Description: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/604/421; Banuelos J., Sabbagh M.D., Roh S.G. et al. Infections following immediate implant-based breast reconstruction: a case-control study over 11 years. Plast Reconstr Surg 2019;144(6):1270–7. DOI:10.1097/PRS.0000000000006202; Ozturk C.N., Ozturk C., Soucise A. et al. Expander/implant removal after breast reconstruction: analysis of risk factors and timeline. Aesthetic Plast Surg 2018;42:64–72. DOI:10.1007/s00266-017-1031-8; Monroig K., Ghosh K., Marquez J.E. et al. Do postoperative prophylactic antibiotics reduce highly virulent infections? An analysis of 660 tissue expander breast reconstructions. Ann Plast Surg 2020;85(S1, Suppl 1):S50–3. DOI:10.1097/SAP.0000000000002325; Phillips B.T., Fourman M.S., Bishawi M. et al. Are prophylactic postoperative antibiotics necessary for immediate breast reconstruction? Results of a prospective randomized clinical trial. J Am Coll Surg 2016;222(6):1116–24. DOI:10.1016/j.jamcollsurg.2016.02.018; Clayton J.L., Bazakas A., Lee C.N. et al. Once is not enough: with holding postoperative prophylactic antibiotics in prosthetic breast reconstruction is associated with an increased risk of infection. Plast Reconstr Surg 2012;130(3):495–502. DOI:10.1097/PRS.0b013e31825dbefe; Gahm J., Ljung Konstantinidou A., Lagergren J. et al. Effectiveness of single vs multiple doses of prophylactic intravenous antibiotics in implant-based breast reconstruction: A randomized clinical trial. JAMA NETw Open 2022;5(9):e2231583. DOI:10.1001/jamaNETworkopen.2022.31583; Weichman K.E., Levine S.M., Wilson S.C. et al. Antibiotic selection for the treatment of infectious complications of implantbased breast reconstruction. Ann Plast Surg 2013;71(2):140–3. DOI:10.1097/SAP.0b013e3182590924
-
9Academic Journal
Authors: N. A. Grigoriev, I. I. Abdullin, A. V. Loginov, E. V. Zhilyaev, Н. А. Григорьев, И. И. Абдуллин, А. В. Логинов, Е. В. Жиляев
Source: Meditsinskiy sovet = Medical Council; № 6 (2022); 68-73 ; Медицинский Совет; № 6 (2022); 68-73 ; 2658-5790 ; 2079-701X
Subject Terms: антибиотикопрофилактика, fosfomycin, prostate biopsy, complications, antibiotic prophylaxix, фосфомицин, биопсия простаты, осложнения
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/6813/6142; Rietbergen J.B., Kruger A.E., Kranse R, Schröder F.H. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology. 1997;49(6):875–880. https://doi.org/10.1016/s0090-4295(97)00100-3.; Balaban M., Ozkaptan O., Sevinc C., Boz M.Y., Horuz R., Kafkasli A., Canguven O. Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases. Int Braz J Urol. 2020;46(1):60–66. https://doi.org/10.1590/S1677-5538.IBJU.2019.0257.; Lavigne J.P., Bruyère F., Bernard L., Combescure C., Ronco E., Lanotte P. et al. Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre study. J Med Microbiol. 2016;65(6): 530–537. https://doi.org/10.1099/jmm.0.000247.; Batura D., Rao G.G., Nielsen P.B. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int. 2010;106(7):1017–1020. https://doi.rg/10.1111/j.1464-410X.2010.09294.x.; Siddiqui M.M., Rais-Bahrami S., Truong H., Stamatakis L., Vourganti S., Nix J. et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013;64(5):713–719. https://doi.org/10.1016/j.eururo.2013.05.059.; Wagenlehner F.M., van Oostrum E., Tenke P., Tandogdu Z., Çek M., Grabe M. et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63(3):521–527. https://doi.org/10.1016/j.eururo.2012.06.003.; Roberts M.J., Bennett H.Y., Harris P.N., Holmes M., Grummet J., Naber K., Wagenlehner F.M.E. Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology. 2017;104:11–21. https://doi.org/10.1016/j.urology.2016.12.011.; Hooper D.C. Mechanisms of Quinolone Resistance. In: Hooper D.C., Rubinstein E. (eds.). Quinolone Antimicrobial Agents. 3rd ed. Washington, D.C.: American Society of Microbiology Press; 2003. 485 pp. Available at: https://openlibrary.org/books/OL8575087M/Quinolone_Antimicrobial_Agents.; Kahlmeter G., ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003;51(1):69–76. https://doi.org/10.1093/jac/dkg028.; Mezzatesta M.L., La Rosa G., Maugeri G., Zingali T., Caio C, Novelli A., Stefani S. In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens. Int J Antimicrob Agents. 2017;49(6):763–766. https://doi.org/10.1016/j.ijantimicag.2017.01.020.; Liss M.A., Nakamura K.K., Meuleners R., Kolla S.B., Dash A., Peterson E.M. Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate? Urology. 2013;82(1):67–71. https://doi.org/10.1016/j.urology.2013.02.068.; Tchesnokova V.L., Ottley L.L., Sakamoto K., Fierer J., Sokurenko E., Liss M.A. Rapid identification of rectal multidrug-resistant Escherichia coli before transrectal prostate biopsy. Urology. 2015;86(6):1200–1205. https://doi.org/10.1016/j.urology.2015.07.008.; Senol S., Tasbakan M., Pullukcu H., Sipahi O.R., Sipahi H., Yamazhan T., Ulusoy S. Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-Producing Escherichia ColiRelated Complicated Lower Urinary Tract Infection. J Chemother. 2010;22(5):355–357. https://doi.org/10.1179/joc.2010.22.5.355.; Gardiner B.J., Mahony A.A., Ellis A.G., Lawrentschuk N., Bolton D.M., Zeglinski P.T. et al. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis. 2014;58(4):e101-e105. https://doi.org/10.1093/cid/cit704.; Falagas M.E., Kastoris A.C., Kapaskelis A.M., Karageorgopoulos D.E. Fosfomycin for the treatment of multidrug-resistant, including extendedspectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010;10(1):43–50. https://doi.org/10.1016/S1473-3099(09)70325-1.; Bennett H.Y., Roberts M.J., Doi S.A., Gardiner R.A. The global burden of major infectious complications following prostate biopsy. Epidemiol Infect. 2016;144(8):1784–1791. https://doi.org/10.1017/s0950268815002885.; Loeb S., Vellekoop A., Ahmed H.U., Catto J., Emberton M., Nam R. et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876–892. https://doi.org/10.1016/j.eururo.2013.05.049.; Park D.S., Oh J.J., Lee J.H., Jang W.K., Hong Y.K., Hong S.K. Simple use of the suppository type povidone-iodine can prevent infectious complications in trasnrectal ultrasound-guided prostate biopsy. Adv Urol. 2009;2009:750598. https://doi.org/10.1155/2009/750598.; Lindert K.A., Kabalin J.N., Terris M.K. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164(1):76–80. Available at: https://pubmed.ncbi.nlm.nih.gov/10840428/.; Bassetti M., Graziano E., Berruti M., Giacobbe D.R. The role of Fosfomycin for multidrug-resistant gram-negative infections. Curr Opin Infect Dis. 2019;32(6):617–625. https://doi.org/10.1097/QCO.0000000000000597.; Khan S.A., Hu K.N., Smith N. Intraoperative preparation of rectum with povidone-iodine-saturated gauze in transrectal biopsy of the prostate. Urology. 1984;23(5 Spec No):104–105. https://doi.org/10.1016/0090-4295(84)90253-x.; Giacometti A., Cirioni O., Grganti G., Fineo A., Ghisell R., Del Prette M.S. et al. Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistente. Eur J Clin Microbiol Inf Dis. 2002;21(7):553–556. https://doi.org/10.1007/s10096-002-0765-6.; Lee J.E., Shin S.S., Kang T.W., Kim J.W., Heo S.H., Jeong Y.Y. Comparison of Different Rectal Cleansing Methods for Reducing Post-Procedural Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsy. Urol J. 2020;17(1):36–41. https://doi.org/10.22037/uj.v0i0.4583.; Sighinolfi M.Ch., Rocco B. EAU Guidelines: Prostate Cancer 2019. Eur Urol. 2019;76(6):871. https://doi.org/10.1016/j.eururo.2019.07.014.; Adrian P., Dimitropoulos K., Veeratterapillay R., Yuan Y., Omar M.I., MacLennan S. et al. Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and MetaAnalysis. J Urol. 2020;204(2):224–230. https://doi.org/10.1097/JU.0000000000001399.
-
10Academic Journal
Authors: A. E. Kuchina, I. N. Zakharova, А. Е. Кучина, И. Н. Захарова
Source: Meditsinskiy sovet = Medical Council; № 6 (2022); 152-157 ; Медицинский Совет; № 6 (2022); 152-157 ; 2658-5790 ; 2079-701X
Subject Terms: антибиотикопрофилактика, caesarean section, obesity, antibiotic prophylaxis, кесарево сечение, ожирение
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/6825/6153; Геппе Н.А. Детские болезни. М.: ГЭОТАР-Медиа; 2018. 760 с.; Тутельян В.А., Конь И.Я. Детское питание. 4-е изд. М.: МИА; 2017. 784 с.; Yuan T., Qi C., Dai X., Xia Y., Sun C., Sun J. et al. Triacylglycerol Composition of Breast Milk during Different Lactation Stages. J Agric Food Chem. 2019;67(8):2272–2278. https://doi.org/10.1021/acs.jafc.8b06554.; Gay M.C.L., Koleva P.T., Slupsky C.M., Toit E.D., Eggesbo M., Johnson C.C. et al. Worldwide Variation in Human Milk Metabolome: Indicators of Breast Physiology and Maternal Lifestyle? Nutrients. 2018;10(9):1151. https://doi.org/10.3390/nu10091151.; Italianer M.F., Naninck E.F.G., Roelants J.A., van der Horst G.T.J., Reiss I.K.M., Goudoever J.B.V. et al. Circadian Variation in Human Milk Composition, a Systematic Review. Nutrients. 2020;12(8):2328. https://doi.org/10.3390/nu12082328.; Bzikowska-Jura A., Sobieraj P., Szostak-Węgierek D., Wesołowska A. Impact of Infant and Maternal Factors on Energy and Macronutrient Composition of Human Milk. Nutrients. 2020;12(9):2591. https://doi.org/10.3390/nu12092591.; Galante L., Lagström H., Vickers M.H., Reynolds C.M., Rautava S., Milan A.M. et al. Sexually Dimorphic Associations between Maternal Factors and Human Milk Hormonal Concentrations. Nutrients. 2020;12(1):152. https://doi.org/10.3390/nu12010152.; Pärnänen K., Karkman A., Hultman J., Lyra C., Bengtsson-Palme J., Larsson D.G.J. et al. Maternal gut and breast milk microbiota affect infant gut antibiotic resistome and mobile genetic elements. Nat Commun. 2018;9(1):3891. https://doi.org/10.1038/s41467-018-06393-w.; Wu M.Q., Wu D.Q., Yang Y., Zhou C.C., Yan C.H. Impact of delivery mode on the levels of essential trace elements in breast milk. J Matern Fetal Neonatal Med. 2020;33(19):3293–3299. https://doi.org/10.1080/14767058.2019.1571035.; Sims C.R., Lipsmeyer M.E., Turner D.E., Andres A. Human milk composition differs by maternal BMI in the first 9 months postpartum. Am J Clin Nutr. 2020;112(3):548–557. https://doi.org/10.1093/ajcn/nqaa098.; Amaral Y.N.D.V.D., Rocha D.M., Silva L.M.L.D., Soares F.V.M., Moreira M.E.L. Do maternal morbidities change the nutritional composition of human milk? A systematic review. Cien Saude Colet. 2019;24(7):2491–2498. https://doi.org/10.1590/1413-81232018247.18972017.; Ortega R.M., López-Sobaler A.M., Martínez R.M., Andrés P., Quintas M.E. Influence of smoking on vitamin E status during the third trimester of pregnancy and on breast-milk tocopherol concentrations in Spanish women. Am J Clin Nutr. 1998;68(3):662–667. https://doi.org/10.1093/ajcn/68.3.662.; Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–11975. https://doi.org/10.1073/pnas.1002601107.; Bokulich N.A., Chung J., Battaglia T., Henderson N., Jay M., Li H. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8(343):343ra82. https://doi.org/10.1126/scitranslmed.aad7121.; Quin C., Gibson D.L. Human behavior, not race or geography, is the strongest predictor of microbial succession in the gut bacteriome of infants. Gut Microbes. 2020;11(5):1143–1171. https://doi.org/10.1080/19490976.2020.1736973.; Grönlund M.M., Lehtonen O.P., Eerola E., Kero P. Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after Cesarean delivery. J Pediatr Gastroenterol Nutr. 1999;28(1):19–25. https://doi.org/10.1097/00005176-199901000-00007.; Rutayisire E., Huang K., Liu Y., Tao F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol. 2016;16(1):86. https://doi.org/10.1186/s12876-016-0498-0.; Hederlingova J., Psenkova P., Zahumensky J. The impact of physiological peripartal stress on the lifelong health of newborn. Bratisl Med J. 2017;118(6):324–327. https://doi.org/10.4149/BLL_2017_063.; Andersen V., Möller S., Jensen P.B., Møller F.T., Green A. Caesarean Delivery and Risk of Chronic Inflammatory Diseases (Inflammatory Bowel Disease, Rheumatoid Arthritis, Coeliac Disease, and Diabetes Mellitus): A Population Based Registry Study of 2,699,479 Births in Denmark During 1973–2016. Clin Epidemiol. 2020;12:287–293. https://doi.org/10.2147/CLEP.S229056.; Hermansson H., Kumar H., Collado M.C., Salminen S., Isolauri E., Rautava S. Breast Milk Microbiota Is Shaped by Mode of Delivery and Intrapartum Antibiotic Exposure. Front Nutr. 2019;6:4. https://doi.org/10.3389/fnut.2019.00004.; Toscano M., De Grandi R., Peroni D. G., Grossi E., Facchin V., Comberiati P., Drago L. Impact of delivery mode on the colostrum microbiota composition. BMC Microbiol. 2017;17(1):205. https://doi.org/10.1186/s12866-017-1109-0.; Cabrera-Rubio R., Collado M.C., Laitinen K., Salminen S., Isolauri E., Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96(3): 544–555. https://doi.org/10.3945/ajcn.112.037382.; Kumar H., du Toit E., Kulkarni A., Aakko J., Linderborg K.M., Zhang Y. et al. Distinct Patterns in Human Milk Microbiota and Fatty Acid Profiles Across Specific Geographic Locations. Front Microbiol. 2016;7:1619. https://doi.org/10.3389/fmicb.2016.01619.; Soto A., Martín V., Jiménez E., Mader I., Rodríguez J.M., Fernández L. Lactobacilli and bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors. J Pediatr Gastroenterol Nutr. 2014;59(1):78–88. https://doi.org/10.1097/MPG.0000000000000347.; Li S.W., Watanabe K., Hsu C.C., Chao S.H., Yang Z.H., Lin Y.J. et al. Bacterial Composition and Diversity in Breast Milk Samples from Mothers Living in Taiwan and Mainland China. Front Microbiol. 2017;8:965. https://doi.org/10.3389/fmicb.2017.00965.; Boix-Amorós A., Collado M.C., Mira A. Relationship between Milk Microbiota, Bacterial Load, Macronutrients, and Human Cells during Lactation. Front Microbiol. 2016;7:492. https://doi.org/10.3389/fmicb.2016.00492.; Moossavi S., Sepehri S., Robertson B., Bode L., Goruk S., Field C.J. et al. Composition and variation of the human milk microbiota are influenced by maternal and early-life factors. Cell Host Microbe. 2019;25(2):324–335. https://doi.org/10.1016/j.chom.2019.01.011.; Williams J.E., Carrothers J.M., Lackey K.A., Beatty N.F., York M.A., Brooker S.L. et al. Human milk microbial community structure is relatively stable and re- lated to variations in macronutrient and micronutrient intakes in healthy lactating women. J Nutr. 2017;147(9):1739–1748. https://doi.org/10.3945/jn.117.248864.; Urbaniak C., Angelini M., Gloor G.B., Reid G. Human milk microbiota profiles in relation to birthing method, gestation and infant gender. Microbiome. 2016;4:1. https://doi.org/10.1186/s40168-015-0145-y.; Corona-Cervantes K., García-González I., Villalobos-Flores L.E., HernándezQuiroz F., Piña-Escobedo A., Hoyo-Vadillo C. et al. Human milk microbiota associated with early colonization of the neonatal gut in Mexican newborns. PeerJ. 2020;8:e9205. https://doi.org/10.7717/peerj.9205.; Pannaraj P., Li F., Cerini C., Bender J., Yang S., Rollie A. et al. Association between breast milk bacterial communities and establishment and development of the infant gut microbiome. JAMA Pediatr. 2017;171(7):647–654. https://doi.org/10.1001/jamapediatrics.2017.0378.; Серов В.Н., Адамян Л.В., Филиппов О.С., Артымук Н.В., Белокриницкая Т.Е., Кан Н.Е. и др. Кесарево сечение. Показания, методы обезболивания, хирургическая техника, антибиотикопрофилактика, ведение послеоперационного периода: клинические рекомендации (протокол лечения). М.; 2014. 44 с. Режим доступа: https://mz.mosreg.ru/upload/iblock/c23/kesarevo-sechenie.pdf.; Smaill F.M., Grivell R.M. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2014;10:CD007482. https://doi.org/10.1002/14651858.; Grech A., Collins C.E., Holmes A., Lal R., Duncanson K., Taylor R., Gordon A. Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis. Gut Microbes. 2021;13(1):1–30. https://doi.org/10.1080/19490976.2021.; Stearns J.C., Simioni J., Gunn E., McDonald H., Holloway A.C., Thabane L. et al. Intrapartum antibiotics for GBS prophylaxis alter colonization patterns in the early infant gut microbiome of low risk infants. Sci Rep. 2017;7(1):16527. https://doi.org/10.1038/s41598-017-16606-9.; Padilha M., Iaucci J.M., Cabral V.P., Diniz E.M.A., Taddei C.R., Saad S.M.I. Maternal antibiotic prophylaxis affects Bifidobacterium spp. counts in the human milk, during the first week after delivery. Benef Microbes. 2019;10(2):155–163. https://doi.org/10.3920/BM2018.0046.; Asbury M.R., Butcher J., Copeland J.K., Unger S., Bando N., Comelli E.M. et al. Mothers of Preterm Infants Have Individualized Breast Milk Microbiota that Changes Temporally Based on Maternal Characteristics. Cell Host Microbe. 2020;28(5):669–682.e4. https://doi.org/10.1016/j.chom.2020.08.001.; Lundgren S.N., Madan J.C., Karagas M.R., Morrison H.G., Hoen A.G., Christensen B.C. Microbial Communities in Human Milk Relate to Measures of Maternal Weight. Front Microbiol. 2019;10:2886. https://doi.org/10.3389/fmicb.2019.02886.; Pammi M., Cope J., Tarr P.I., Warner B.B., Morrow A.L., Mai V. et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome. 2017;5(1):31. https://doi.org/10.1186/s40168-017-0248-8.; Patel N., Pasupathy D., Poston L. Determining the consequences of maternal obesity on offspring health. Exp Physiol. 2015;100(12): 1421–1428. https://doi.org/10.1113/EP085132.; Godfrey K.M., Reynolds R.M., Prescott S.L., Nyirenda M., Jaddoe V.W., Eriksson J.G., Broekman B.F. Influence of maternal obesity on the longterm health of offspring. Lancet Diabetes Endocrinol. 2017;5(1):53–64. https://doi.org/10.1016/S2213-8587(16)30107-3.; Mueller N.T., Mao G., Bennet W.L., Hourigan S.K., Dominguez-Bello M.G., Appel L.J., Wang X. Does vaginal delivery mitigate or strengthen the intergenerational association of overweight and obesity? Findings from the Boston Birth Cohort. Int J Obes (Lond). 2017;41(4):497–501. https://doi.org/10.1038/ijo.2016.219.; Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214. https://doi.org/10.1126/science.1241214.; Crovesy L., Masterson D., Rosado E.L. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020;74(9):1251–1262. https://doi.org/10.1038/s41430-020-0607-6.; Collado M., Laitinen K., Salminen S. Isolauri E. Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr Res. 2012;72(1):77–85. https://doi.org/10.1038/pr.2012.42.; Collado M.C., Isolauri E., Laitinen K., Salminen S. Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92(5):1023–1030. https://doi.org/10.3945/ajcn.2010.29877.; Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 2008;88(4):894–899. https://doi.org/10.1093/ajcn/88.4.894.; Davé V., Street K., Francis S., Bradman A., Riley L., Eskenazi B. et al. Bacterial microbiome of breast milk and child saliva from low-income Mexican-American women and children. Pediatr Res. 2016;79(6):846–854. https://doi.org/10.1038/pr.2016.9.; Ding M., Qi C., Yang Z., Jiang S., Bi Y., Lai J. et al. Geographical location specific composition of cultured microbiota and Lactobacillus occurrence in human breast milk in China. Food Funct. 2019;10(2):554–564. https://doi.org/10.1039/c8fo02182a.; Böttcher M.F., Abrahamsson T.R., Fredriksson M., Jakobsson T., Björkstén B. Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol. 2008;19(6):497–504. https://doi.org/10.1111/j.1399-3038.2007.00687.x.; Snijders B.E., Stelma F.F., Reijmerink N.E., Thijs C., van der Steege G., Damoiseaux J.G. et al. CD14 polymorphisms in mother and infant, soluble CD14 in breast milk and atopy development in the infant (KOALA Study). Pediatr Allergy Immunol. 2010;21(3):541–549. https://doi.org/10.1111/j.1399-3038.2009.00939.x.; Hashemi-Nazari S.S., Hasani J., Izadi N., Najafi F., Rahmani J., Naseri P. et al. The effect of pre-pregnancy body mass index on breastfeeding initiation, intention and duration: A systematic review and dose-response meta-analysis. Heliyon. 2020;6(12):e05622. https://doi.org/10.1016/j.heliyon.2020.e05622.; Takahashi K., Ganchimeg T., Ota E., Vogel J.P., Souza J.P., Laopaiboon M. et al. Prevalence of early initiation of breastfeeding and determinants of delayed initiation of breastfeeding: secondary analysis of the WHO Global Survey. Sci Rep. 2017;7:44868. https://doi.org/10.1038/srep44868.
-
11Academic Journal
Authors: Nychytailo, M. Yu., Bulyk, I. I.
Source: Surgery of Ukraine; No. 2 (2018); 70-73
Хирургия Украины; № 2 (2018); 70-73
Хірургія України; № 2 (2018); 70-73Subject Terms: гострий калькульозний холецистит, гострий панкреатит, acute pancreatitis, антибиотикотерапия, antibiotic prophylaxis, choledocholithiasis, bile duct obstruction, холедохолітіаз, антибіотикотерапія, ципрофлоксацин, холедохолитиаз, острый панкреатит, 3. Good health, непрохідність жовчних проток, антибиотикопрофилактика, острый калькулезный холецистит, ciprofloxacin, antibiotic therapy, антибіотикопрофілактика, acute calculous cholecystitis, непроходимость желчных протоков
File Description: application/pdf
Access URL: https://surgukraine.co.ua/article/view/SU2018270
-
12Academic Journal
Authors: A. G. Kedrova, S. A. Levakov, N. S. Vanke
Source: Опухоли женской репродуктивной системы, Vol 14, Iss 1, Pp 86-90 (2018)
Subject Terms: антибиотикопрофилактика, гистерэктомия, 2. Zero hunger, 03 medical and health sciences, 0302 clinical medicine, овариотомия, орнидазол и офлоксацин, RG1-991, Gynecology and obstetrics, инфекционные послеоперационные осложнения, 3. Good health
Access URL: https://ojrs.abvpress.ru/ojrs/article/download/582/569
https://doaj.org/article/b659a9a3711244b599e98f4df61a1a7f
https://ojrs.abvpress.ru/ojrs/article/view/582
https://cyberleninka.ru/article/n/opyt-pred-i-postoperatsionnoy-antibiotikoprofilaktiki-s-uchetom-individualnyh-faktorov-riska-ginekologicheskih-bolnyh
https://ojrs.abvpress.ru/ojrs/article/download/582/569 -
13Academic Journal
Authors: Петренко, Є.В., Струбчевська, К.Р.
Source: Reproductive health of woman; No. 3 (2021); 57-64 ; Reproductive health of woman; № 3 (2021); 57-64 ; Репродуктивне здоров'я жінки; № 3 (2021); 57-64 ; 2708-8731 ; 2708-8723
Subject Terms: preterm labor, risk factors, diagnostic tests, tocolytic treatment, antibiotic prophylaxis, progesterone supplementation, cervical cerclage, cervical pessary, преждевременные роды, факторы риска, диагностические тесты, токолитическая терапия, антибиотикопрофилактика, использование прогестерона, шов на шейку матки, акушерский пессарий, передчасні пологи, фактори ризику, діагностичні тести, токолітична терапія, антибіотикопрофілактика, застосування прогестерону, серкляж на шийку матки, акушерський песарій
File Description: application/pdf
-
14Academic Journal
Authors: N. A. Grigoryev, I. I. Abdullin, B. R. Gvasalia, A. V. Loginov, E. V. Zhilyaev, Н. А. Григорьев, И. И. Абдуллин, Б. Р. Гвасалия, А. В. Логинов, Е. В. Жиляев
Source: Andrology and Genital Surgery; Том 22, № 3 (2021); 49-55 ; Андрология и генитальная хирургия; Том 22, № 3 (2021); 49-55 ; 2412-8902 ; 2070-9781
Subject Terms: антибиотикопрофилактика, fusion-biopsy of prostate, antibiotic prophylaxis, фьюжн-биопсия предстательной железы
File Description: application/pdf
Relation: https://agx.abvpress.ru/jour/article/view/506/428; Rietbergen J.B., Kruger A.E., Kranse R., Schröder F.H. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49(6):875–80. DOI:10.1016/s0090-4295(97)00100-3.; Ouzzane A., Coloby P., Mignard J.P. et al. [Recommendations for best practice for prostate biopsy (In French)]. Prog Urol 2011;21(1):18–28. DOI:10.1016/j.purol.2010.07.001.; Ehdaie B., Vertosick E., Spaliviero M. et al. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol 2014;191(3):660–4. DOI:10.1016/j.juro.2013.08.088.; Wolf J.S., Bennett C.J., Dmochowski R.R. et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. AUA Guidelines. J Urol 2008;179(4):1379–90. DOI:10.1016/j.juro.2008.01.068.; Lavigne J.P., Bruyère F., Bernard L. et al. Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre study. J Med Microbiol 2016;65(6):530–7. DOI:10.1099/jmm.0.000247.; Batura D., Rao G.G., Nielsen P.B. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 2010;106(7):1017–20. DOI:10.1111/j.1464-410X.2010.09294.x.; Siddiqui M.M., Rais-Bahrami S., Truong H. Magnetic resonance imaging/ ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013;64(5):713–9. DOI:10.1016/j.eururo.2013.05.059.; Hooper D.C. Mechanisms of quinolone resistance. In: Hooper D.C., Rubinstein E., eds. Quinolone antimicrobial agents. 3 rd ed. Washington, DC: ASM Press, 2003. Pp. 41–67.; Kahlmeter G. ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003;51(1):69–76. DOI:10.1093/jac/dkg028.; Carignan A., Roussy J.F., Lapointe V. et al. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 2012;62(3):453–9. DOI:10.1016/j.eururo.2012.04.044.; Mezzatesta M.L., La Rosa G., Maugeri G. et al. In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens. Int J Antimicrob Agents 2017;49(6):763–6. DOI:10.1016/j.ijantimicag.2017.01.020.; Senol S., Tasbakan M., Pullukcu H. et al. Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection. J Chemother 2010;22(5):355–7. DOI:10.1179/joc.2010.22.5.355.; Gardiner B.J., Mahony A.A., Ellis A.G. et al. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis 2014;58(4):e101–5. DOI:10.1093/cid/cit704.; Falagas M.E., Kastoris A.C., Kapaskelis A.M., Karageorgopoulos D.E. Fosfomycin for the treatment of multidrug-resistant, including extendedspectrum beta-lactamase producing Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010;10(1):43–50. DOI:10.1016/S1473-3099(09)70325-1.; Park D.S., Oh J.J., Lee J.H. et al. Simple use of the suppository type povidone-iodine can prevent infectious complications in trasnrectal ultrasound-guided prostate biopsy. Adv Urol 2009;2009:750598. DOI:10.1155/2009/750598.; Lindert K.A., Kabalin J.N., Terris M.K. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000;164:76–80. PMID: 10840428.; Khan S.A., Hu K.N., Smith N. Intraoperative preparation of rectum with povidone-iodine-saturated gauze in transrectal biopsy of the prostate. Urology 1984;23(5 Spec No):104–5. DOI:10.1016/0090-4295(84)90253-x.; Giacometti A., Cirioni O., Greganti G. et al. Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistente. Eur J Clin Microbiol Inf Dis 2002;21(7):553–6. DOI:10.1007/s10096-002-0765-6.; Sighinolfi M.Ch., Rocco B. EAU Guidelines: Prostate Cancer 2019. Eur Urol 2019;76(6):871. DOI:10.1016/j.eururo.2019.07.014.; Pilatz A., Dimitropoulos K., Veeratterapillay R. et al. Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis. J Urol 2020;204(2):224–30. DOI:10.1097/JU.0000000000000814.; https://agx.abvpress.ru/jour/article/view/506
-
15Academic Journal
Source: Репродуктивне здоров'я жінки; № 3 (2021); 57-64
Reproductive health of woman; № 3 (2021); 57-64
Reproductive health of woman; No. 3 (2021); 57-64Subject Terms: preterm labor, progesterone supplementation, antibiotic prophylaxis, cervical cerclage, токолітична терапія, использование прогестерона, фактори ризику, факторы риска, токолитическая терапия, акушерский пессарий, 3. Good health, серкляж на шийку матки, антибиотикопрофилактика, акушерський песарій, diagnostic tests, tocolytic treatment, risk factors, антибіотикопрофілактика, передчасні пологи, диагностические тесты, шов на шейку матки, діагностичні тести, cervical pessary, застосування прогестерону, преждевременные роды
File Description: application/pdf
Access URL: http://repro-health.com.ua/article/view/234245
-
16Academic Journal
Authors: А. И. Прудков, И. Д. Анферов, Д. И. Анферов, К. Е. Федорова, Я. М. Мезенина, А. С. Струихин, Е. В. Нишневич, Владимир Александрович Руднов
Source: Вестник интенсивной терапии, Iss 3 (2020)
Subject Terms: ожирение, антибиотикопрофилактика, бариатрическая хирургия, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
File Description: electronic resource
-
17Academic Journal
Authors: A. O. Guz, D. M. Fatkullin, A. V. Garev, A. S. Zakharov, M. I. Sokolova, A. P. Alekseeva, А. О. Гузь, Д. М. Фаткуллин, А. В. Гарев, А. С. Захаров, М. И. Соколова, А. П. Алексеева
Source: Head and Neck Tumors (HNT); Том 10, № 2 (2020); 54-60 ; Опухоли головы и шеи; Том 10, № 2 (2020); 54-60 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2020-10-2
Subject Terms: клиндамицин, antibiotic prophylaxis, surgical wound infection, clean wounds, clean-contaminated wounds, lymphadenectomy, free flap, cephalosporins, clindamycin, антибиотикопрофилактика, хирургическая раневая инфекция, чистые раны, условночистые раны, лимфаденэктомия, свободный лоскут, цефалоспорины
File Description: application/pdf
Relation: https://ogsh.abvpress.ru/jour/article/view/527/424; Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. DOI:10.3322/caac.21492.; Состояние онкологической помощи населению России в 2017 году. Под ред. В.В. Старинского, А.Д. Каприна, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена, 2018. 236 c. [State of oncological care in Russia in 2017. Ed. by А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P.A. Hertsen Moscow Oncology Research Center, 2018. 236 p. (In Russ.)].; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7–34. DOI:10.3322/caac.21551.; Gatta G., Botta L., Sánchez M.J. et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 populationbased study. Eur J Cancer 2015;51(15):2130–43. DOI:10.1016/j.ejca.2015.07.043.; Becker G.D., Parell G.J. Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 1979;88(2 Pt 1):183–6. DOI:10.1177/000348947908800206.; Herranz J., Sarandeses A., Fernández M.F. et al. Complications after total laryngectomy in nonradiated laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg 2000;122(6):892–8. DOI:10.1016/S0194-59980070020-9.; Crippen M.M., Patel N., Filimonov A. et al. Association of smoking tobacco with complications in head and neck microvascular reconstructive surgery. JAMA Facial Plast Surg 2019;21(1):20–6. DOI:10.1001/jamafacial.2018.1176.; Lahtinen S., Koivunen P., Ala-Kokko T. et al. Quality of life after free flap surgery for cancer of the head and neck in patients with or without postoperative complications. Eur Arch Otorhinolaryngol 2018;275(10):2575–84. DOI:10.1007/s00405-018-5103-4.; Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. Доступно по: http://www. antibiotic.ru/ab/147-149.shtml. [A practical guide to anti-infectious chemotherapy. Ed. by L.S. Strachunsky, Yu.B. Belousov, S.N. Kozlov. Available at: http://www.antibiotic.ru/ab/147-149.shtml. (In Russ.)].; Ortega G., Rhee D.S., Papandria D.J. et al. An evaluation of surgical site infections by wound classification system using the ACS-NSQIP. J Surg Res 2012;174(1):33–8. DOI:10.1016/j.jss.2011.05.056.; Bratzler D.W., Dellinger E.P., Olsen K.M. et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013;14(1):73–156. DOI:10.1089/sur.2013.9999.; Cruse P.J., Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60(1):27–40. DOI:10.1016/s0039-6109(16)42031-1.; Haley R.W., Culver D.H., Morgan W.M. et al. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121(2):206–15. DOI:10.1093/oxfordjournals.aje.a113991.; Olson M., O’Connor M., Schwartz M.L. Surgical wound infections. A 5-year prospective study of 20,193 wounds at the Minneapolis VA Medical Center. Ann Surg 1984;199(3):253–9. DOI:10.1097/00000658-198403000-00001.; Culver D.H., Horan T.C., Gaynes R.P. et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991;91(3B):152S–7S. DOI:10.1016/0002-9343(91)90361-z.; Busch C.-J., Knecht R., Münscher A. et al. Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study. Eur Arch Otorhinolaryngol 2016;273(9):2805–11. DOI:10.1007/s00405-015-3856-6.; Johnson J.T., Yu V.L., Myers E.N., Wagner R.L. An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 1987;155(2):331–3. DOI:10.1093/infdis/155.2.331.; Murdoch D.A., Telfer M.R., Irvine G.H. Audit of antibiotic policy and wound infection in neck surgery. J R Coll Surg Edinb 1993;38(3):167–9.; Weber R.S., Callender D.L. Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol Suppl 1992;155:16–20. DOI:10.1177/00034894921010S104.; Avenia N., Sanguinetti A., Cirocchi R. et al. Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric Italian experience. Ann Surg Innov Res 2009;3:10. DOI:10.1186/1750-1164-3-10.; Carrau R.L., Byzakis J., Wagner R.L., Johnson J.T. Role of prophylactic antibiotics in uncontaminated neck dissections. Arch Otolaryngol Head Neck Surg 1991;117(2):194–5. DOI:10.1001/archotol.1991.01870140082011.; Man L.-X., Beswick D.M., Johnson J.T. Antibiotic prophylaxis in uncontaminated neck dissection. Laryngoscope 2011;121(7):1473–7. DOI:10.1002/lary.21815.; Coskun H., Erisen L., Basut O. Factors affecting wound infection rates in head and neck surgery. Otolaryngol Head Neck Surg 2000;123(3):328–33. DOI:10.1067/mhn.2000.105253.; Seven H., Sayin I., Turgut S. Antibiotic prophylaxis in clean neck dissections. J Laryngol Otol 2004;118(3):213–6. DOI:10.1258/002221504322927991.; Ketcham A.S., Bloch J.H., Crawford D.T. et al. The role of prophylactic antibiotic therapy in control of staphylococcal infections following cancer surgery. Surg Gynecol Obstet 1962;114:345–52.; Dor P., Klastersky J. Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (a double-blind study). Laryngoscope 1973;83(12):1992–8. DOI:10.1288/00005537-197312000-00009.; Saginur R., Odell P.F., Poliquin J.F. Antibiotic Prophylaxis in head and neck cancer surgery. J Otolaryngol 1988;17(2):78-80.; Sepehr A., Gutierrez Santos B.-J., Chou C. et al. Antibiotics in head and neck surgery in the setting of malnutrition, tracheotomy, and diabetes. Laryngoscope 2009;119(3):549–53. DOI:10.1002/lary.20078.; Langerman A., Thisted R., Hohmann S., Howell M. Antibiotic and duration of perioperative prophylaxis predicts surgical site infection in head and neck surgery. Otolaryngol Head Neck Surg 2016;154(6):1054–63. DOI:10.1177/0194599816634303.; Simo R., French G. The use of prophylactic antibiotics in head and neck oncological surgery. Curr Opin Otolaryngol Head Neck Surg 2006;14(2):55–61. DOI:10.1097/01.moo.0000193183.30687.d5.; Vila P.M., Zenga J., Jackson R.S. Antibiotic prophylaxis in cleancontaminated head and neck surgery: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2017;157(4):580–8. DOI:10.1177/0194599817712215.; Программа СКАТ (Стратегия Контроля Антимикробной Терапии) при оказании стационарной медицинской помощи. Российские клинические рекомендации. М., 2018. Доступно по: http://nasci.ru/?id=2880. [SATC (Strategy of Antimicrobial Therapy Control). Moscow, 2018. Available at: http://nasci.ru/?id=2880. (In Russ.)].; Профилактика инфекций области хирургического вмешательства. Клинические рекомендации. Н. Новгород: Ремедиум Приволжье, 2018. Доступно по: http://nasci.ru/?id=2260. [Prevention of Infections in the Area of Surgical Intervention. Nizhny Novgorod: Remedium Povolzh’e, 2018. Available at: http://nasci.ru/?id=2260. (In Russ.)].; Berríos-Torres S.I., Umscheid C.A., Bratzler D.W. et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 2017;152(8):784–91. DOI:10.1001/jamasurg.2017.0904.; Fee W.E. Jr, Glenn M., Handen C., Hopp M.L. One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Laryngoscope 1984;94(5 Pt 1):612–4.; Johnson J.T., Schuller D.E., Silver F. et al. Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs. five-day therapy. Otolaryngol Head Neck Surg 1986;95(5):554–7. DOI:10.1177/019459988609500506.; Bhathena H.M., Kavarana N.M. Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime. Acta Chir Plast 1998;40(2):36–40.; Liu S.A., Tung K.-C., Shiao J.-Y., Chiu Y.-T. Preliminary report of associated factors in wound infection after major head and neck neoplasm operations – does the duration of prophylactic antibiotic matter? J Laryngol Otol 2008;122(4):403–8. DOI:10.1017/S0022215107007529.; Righi M., Manfredi R., Farneti G. et al. Clindamycin/cefonicid in head and neck oncologic surgery: one-day prophylaxis is as effective as a three-day schedule. J Chemother 1995;7(3):216–20. DOI:10.1179/joc.1995.7.3.216.; Villanueva J.M., Araya I.C., Yanine N.M. Short-term antibiotic prophylaxis versus long-term antibiotic prophylaxis in major clean-contaminated maxillofacial surgery. Rev Chilena Infectol 2012;29(1):14–8. DOI:10.4067/s0716-10182012000100002.; Haidar Y.M., Tripathi P.B., Tjoa T. et al. Antibiotic prophylaxis in cleancontaminated head and neck cases with microvascular free flap reconstruction: a systematic review and meta-analysis. Head Neck 2018;40(2):417–27. DOI:10.1002/hed.24988.; https://ogsh.abvpress.ru/jour/article/view/527
-
18Academic Journal
Source: Эндодонтия Today, Vol 12, Iss 3, Pp 39-40 (2020)
Subject Terms: инсульт, стоматологическая реабилитация, антибиотикопрофилактика, гемодинамика, международное нормализованное отношение, stroke, dental rehabilitation, antibiotic prophylaxis, hemodynamics, international normalized ratio, Dentistry, RK1-715
-
19Academic Journal
Authors: Kostiyk, E.A., Shynko, E.E., Krasnova, Y.Y.
Source: Neonatology, Surgery and Perinatal Medicine; Vol. 4 No. 3(13) (2014): Неонатологія, хірургія та перинатальна медицина; 104-109 ; Неонатология, хирургия и перинатальная медицина; Том 4 № 3(13) (2014): Неонатологія, хірургія та перинатальна медицина; 104-109 ; Неонатологія, хірургія та перинатальна медицина; Том 4 № 3(13) (2014): Неонатологія, хірургія та перинатальна медицина; 104-109 ; 2413-4260 ; 2226-1230
Subject Terms: новонароджені, сепсис, ранній неонатальний сепсис, чинники ризику, хоріонамніоніт, антибіотикопрофілактика у пологах, стрептококи групи В, бактеріологічне дослідження крові, загальний аналіз крові, С-реактивний білок, антибактеріальна терапія, новорожденные, ранний неонатальный сепсис, факторы риска, хорионамнионит, антибиотикопрофилактика в родах, стрептококки группы В, бактериологическое исследование крови, общий анализ крови, С-реактивный белок, антибактериальная терапия, newborns, sepsis, early onset sepsis, risk factors, chorionamnionitis, antibiotic prophylaxis in labour, group B streptococcus, blood culture, white blood count
File Description: application/pdf
-
20Academic Journal
Source: Эндодонтия Today, Vol 12, Iss 3, Pp 39-40 (2020)
Subject Terms: инсульт, стоматологическая реабилитация, антибиотикопрофилактика, гемодинамика, международное нормализованное отношение, stroke, dental rehabilitation, antibiotic prophylaxis, hemodynamics, international normalized ratio, Dentistry, RK1-715
File Description: electronic resource